214 related articles for article (PubMed ID: 7719416)
1. Increased bile acid concentration in liver tissue with cholesterol gallstone disease.
Honda A; Yoshida T; Tanaka N; Matsuzaki Y; He B; Shoda J; Osuga T
J Gastroenterol; 1995 Feb; 30(1):61-6. PubMed ID: 7719416
[TBL] [Abstract][Full Text] [Related]
2. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
Carulli N; Ponz De Leon M; Zironi F; Pinetti A; Smerieri A; Iori R; Loria P
J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253
[TBL] [Abstract][Full Text] [Related]
3. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
Nilsell K
Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
[No Abstract] [Full Text] [Related]
4. Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster model.
Pearlman BJ; Bonorris GG; Phillips MJ; Chung A; Vimadalal S; Marks JW; Schoenfield LJ
Gastroenterology; 1979 Oct; 77(4 Pt 1):634-41. PubMed ID: 467920
[TBL] [Abstract][Full Text] [Related]
5. Portal venous bile acids in cholesterol gallstone disease: effect of treatment with chenodeoxycholic and cholic acids.
Einarsson K; Ahlberg J; Angelin B; Björkhem I; Ewerth S
Hepatology; 1985; 5(4):661-5. PubMed ID: 4018738
[TBL] [Abstract][Full Text] [Related]
6. Hepatic cholesterol and bile acid synthesis in Japanese patients with cholesterol gallstones.
Honda A; Yoshida T; Tanaka N; Matsuzaki Y; He B; Osuga T; Kobayashi N; Ozawa K
Gastroenterol Jpn; 1993 Jun; 28(3):406-14. PubMed ID: 8344502
[TBL] [Abstract][Full Text] [Related]
7. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
8. Effects of chenodeoxycholic and ursodeoxycholic acids on lipid metabolism and gallstone formation in the prairie dog.
Cohen BI; Singhal AK; Stenger RJ; May-Donath P; Finver-Sadowsky J; McSherry CK; Mosbach EH
Hepatology; 1984; 4(2):300-7. PubMed ID: 6706304
[TBL] [Abstract][Full Text] [Related]
9. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
[TBL] [Abstract][Full Text] [Related]
10. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
11. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.
Nilsell K; Angelin B; Liljeqvist L; Einarsson K
Gastroenterology; 1985 Aug; 89(2):287-93. PubMed ID: 4007420
[TBL] [Abstract][Full Text] [Related]
12. Alteration of biliary ursodeoxycholic acid in guinea pig during early stages of cholestyramine feeding.
Li JR; Dinh DM; Kottke BA
Steroids; 1979; 34(6 Spec no):705-15. PubMed ID: 538776
[TBL] [Abstract][Full Text] [Related]
13. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
[TBL] [Abstract][Full Text] [Related]
14. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.
Okamoto S; Nakano K; Kosahara K; Kishinaka M; Oda H; Ichimiya H; Chijiiwa K; Kuroki S
J Gastroenterol; 1994 Feb; 29(1):47-55. PubMed ID: 8199696
[TBL] [Abstract][Full Text] [Related]
15. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
Northfield TC; Hofmann AF
Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
[TBL] [Abstract][Full Text] [Related]
16. Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.
Hillebrant C; Nyberg B; Angelin B; Axelson M; Björkhem I; Rudling M; Einarsson C
J Intern Med; 1999 Oct; 246(4):399-407. PubMed ID: 10583711
[TBL] [Abstract][Full Text] [Related]
17. Biochemical epidemiology of gallbladder cancer.
Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
[TBL] [Abstract][Full Text] [Related]
18. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
[TBL] [Abstract][Full Text] [Related]
19. Replacement of cholesterol gallstones by murideoxycholyl taurine gallstones in prairie dogs fed murideoxycholic acid.
Cohen BI; Ayyad N; Mosbach EH; McSherry CK; Matoba N; Hofmann AF; Ton-Nu HT; Peng Y; Schteingart CD; Stenger RJ
Hepatology; 1991 Jul; 14(1):158-68. PubMed ID: 2066064
[TBL] [Abstract][Full Text] [Related]
20. 7-Methyl bile acids: effects of chenodeoxycholic acid, cholic acid, and their 7 beta-methyl analogues on the formation of cholesterol gallstones in the prairie dog.
Matoba N; Cohen BI; Mosbach EH; Stenger RJ; Kuroki S; Une M; McSherry CK
Gastroenterology; 1989 Jan; 96(1):178-85. PubMed ID: 2909419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
